Nexalin gets Nasdaq panel approval to stay listed; must hit $1.00 bid by Sept 28 and $2.5M equity by Jan 4

Nexalin Technology, Inc.

Nasdaq Hearings Panel granted continued listing on Sept 25, 2026, conditioned on meeting the minimum bid price and $2,500,000 stockholders' equity requirements.
Company must show compliance with the $1.00 minimum bid price rule by Sept 28, 2026, including a $1.00+ closing bid for 20 consecutive sessions under Rule 5815(c)(4).
Deadline of January 4, 2027 set to demonstrate the $2,500,000 minimum stockholders' equity requirement under Nasdaq Listing Rule 5550(b)(1).
Earlier staff determinations on July 24 and Aug 17, 2026 cited failures of the minimum bid price test and both Rule 5550(b) alternatives, and a miss of the $5,000,000 initial listing equity test.
Shares continue trading on the Nasdaq Capital Market during the exception period; failure to meet the conditions would subject the stock to delisting.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.